ProfileGDS5822 / ILMN_2859539
TitleAnti-CTLA-4 immunotherapy effect on αSMA+ myofibroblast late-depleted pancreatic ductal adenocarcinoma model
OrganismMus musculus


control myofibroblast depletion untreated anti-CTLA4 antibody GSM1276599 GSM1276600 GSM1276601 GSM1276602 GSM1276603 GSM1276604 GSM1303940 GSM1303941 GSM1303942 67% 46% 23% 52% 53% 38% 65% 17% 60% sort by protocol sort by agent Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM1276599PDAC Late Ablation Control 140.967
GSM1276600PDAC Late Ablation Control 222.246
GSM1276601PDAC Late Ablation Control 37.723
GSM1276602PDAC Late Ablation 120.552
GSM1276603PDAC Late Ablation 224.653
GSM1276604PDAC Late Ablation 318.638
GSM1303940PDAC Late Ablation_anti-CTLA4 134.965
GSM1303941PDAC Late Ablation_anti-CTLA4 29.517
GSM1303942PDAC Late Ablation_anti-CTLA4 33760